Income Statement Presentation 2023

2022: Royalties and other operating income Higher income driven by one-time Ultomiris patent settlement gains CHFM 3,049 -611 +116 +713 -122 Royalties and other operating income increased by +3% at CER 3,145 2021 Royalty income Out-licensing Income (incl. Ultomiris) Other operating income incl. Income from disp. of products 2022 Ronapreve profit share income CER Constant Exchange Rates Roche 53

View entire presentation